Medtronic Wins $101 Million in Patent Case Against NuVasive

Medtronic Inc. won a $101.2 million jury award in a patent-infringement trial against NuVasive Inc. over claims related to medical devices used in spinal surgery. NuVasive dropped as much as 8.4 percent in Nasdaq trading.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.